Role of octreotide in the treatment of external pancreatic pure fistulas: A single-institution prospective experience

Claudio Bassi, Massimo Falconi, Roberto Salvia, Erminia Caldiron, Giovanni Butturini, Paolo Pederzoli

Research output: Contribution to journalArticle

Abstract

Introduction: Octreotide was studied in the treatment of pure external pancreatic fistulas. Methods: Eighteen cases (12 males, 6 females) were prospectively observed. Six patients (four after radical surgery for periampullary cancer, one endocrine tumor enucleation and one pancreojejunostomy in chronic pancreatitis) were treated as outpatients with octreotide alone because of low basal fistula output (mean±SD: 96.6±27.4 cc/24 h). Twelve (five radical surgery for cancer, five surgery for severe pancreatitis, one enucleation and one pancreojejunostomy) were treated as inpatients with octreotide plus total parenteral nutrition because of the high output (mean±SD: 448.4±248.2 cc/24 h). Results: Ten of the 12 high- output fistulas healed in 27.8±27.7 days, whereas all low-output fistulas healed in 12.1 ± 6.6 days. Conclusion: Octreotide appears useful in the treatment of external pancreatic fistulas. For optimal results to be achieved, there must be no local infection and no mechanical or anatomical obstacles to the free flow of juice.

Original languageEnglish
Pages (from-to)10-13
Number of pages4
JournalLangenbeck's Archives of Surgery
Volume385
Issue number1
Publication statusPublished - Jan 2000

Keywords

  • External pancreatic fistulas
  • Octreotide
  • Pancreatic cancer
  • Pancreatic surgery
  • Pancreatitis

ASJC Scopus subject areas

  • Surgery

Fingerprint Dive into the research topics of 'Role of octreotide in the treatment of external pancreatic pure fistulas: A single-institution prospective experience'. Together they form a unique fingerprint.

  • Cite this